Biotech Company Pops After Clinical Study

DWAC, Truth Social Struggle to Solidfy Multi-Billion Dollar Deal‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Good morning Wake-Up Watchlisters! While you're sipping your post Labor Day coffee you'll see stock futures rose on Tuesday. Investors were attracted to lower prices after three weeks of Wall Street declines. The focus will be on the ECB this week, as rate hikes of 75 points are expected on Thursday. It's no secret the markets have been rough in 2022. Which is why we're helping War Room members profit and protect themselves with this 'Crash-Proof Asset.' Click here to unlock this recession-proof play. IVERIC bio (Nasdaq: ISEE) IVERIC bio is up 40.47% premarket after the company received positive topline data from a clinical study of ZimuraTM GATHER2. Zimura is a investigational C5 inhibitor, used for the treatment of geographic atrophy of the retina. The company plans to submit a new drug application to the FDA in the first quarter of 2023. Our friend Alexander Green wants you to know about another game-changing medical stock. Right now this $4 company is up 66.3% since May 11, 2022. And they just won the 2022 MedTech Breakthrough Award. Click here to unlock this $4 stock. MannKind (Nasdaq: MNKD) MannKind is up 10.05% premarket after successfully completing its Phase 1 study of inhaled clofazimine. The company is focused on the development and commercialization of inhaled therapeutic products with endocrine and orphan lung diseases. Clofazimine is being developed as an inhalation treatment for nontuberculous mycobacterial (NTM) lung disease. Mind-Blowing Stock Story THIS can't be right, can it? What the son of a police officer did with $7,500 is ALL-TIME crazy... Check out the shocking true story here. Bed, Bath & Beyond (Nasdaq: BBBY) Bed, Bath & Beyond is down 15.53% premarket after the death of Chief Financial Officer Gustavo Arnal, which was ruled a suicide by New York City's Medical Examiner. Shares of BBBY have been on a rollercoaster this year. It slumped after the home goods retailer unveiled a turnaround program last week, and went up earlier in August after activist investor Ryan Cohen bought a stake. Digital World Acquisition Group (Nasdaq: DWAC) Digital World Acquisition Group is down 21.97% premarket after as the company struggles with delays amid its merger with Truth Social, Donald Trump's fledging media group. The deal has been delayed by a series of investigations into Truth Social's dealings with Digital World, and could put an end to the multi-billion deal unless 65% of Digital World shareholders voice support for the deal. Do you know how 'Follow the Money' to profits? If you want to know how earnings reports could play out, following insdier buying (the legal kind) can be an effective way. Our Head Fundamental Tactician Karim Rahemtulla specializes in tracking insider buying, and knowing this information could help you record gains as high as 2,250%. Click here to see how we 'follow the money.' Those are the top market movers today. Happy trading! The Wake-Up Watchlist Research Team Bargain in Today's Market (SHOCKING) This "World's Most Admired" company's stock would be a bargain at $50... Today it's just under $2! Plus... a key announcement in December, could send it ROCKETING skyward... Click Here Now (Before It's Too Late!) Monument Traders Alliance   You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, click here. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 Website | Privacy Policy Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day. © 2022 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.